Stock Market News for July 24, 2026

Telecom and large-cap results

Verizon (VZ) posted record 2Q26 results, driven by its strategic transformation and accelerating wireless and broadband growth; the beat sharpens the market outlook as capex ramps for network upgrades. Read the company release.

Transport, shipping and industrials

Canadian National Railway (CNI) delivered strong 2Q results and raised 2026 guidance, a signal that freight cyclicality is improving and pricing is supporting margins. See the release.

Energy, miners and commodity trading

TotalEnergies (TTE) published its first-half 2026 financial report, providing direct insight into cash generation, capex plans and the company’s market outlook amid volatile oil and gas prices. Read the report.

Vivakor (VIVK) said it surpassed $1 billion in annualized physical crude transactions, a milestone that underscores scale in commodity flow and trading operations and could influence revenue visibility for mid‑tier energy merchants. See the announcement.

CS PowerTech (CSIQ) launched a PV HJT solar cell plant, expanding capacity for high‑efficiency modules at a time when module supply tightness matters for project economics. Read the announcement.

AngloGold Ashanti (AU) released results from its general meeting; governance moves at major miners can affect project timelines and investors’ appetite for gold exposure. See the outcome.

Financials, payments and banks

American Express (AXP) reported resilient consumer spending and travel gains in 2Q26; investors will watch guidance and margin leverage as premium‑card growth is monetized. See the earnings statement.

Bank First (BFC) announced net income for 2Q26, a routine but relevant data point for regional bank performance and net interest income trends. Read the release.

Western Alliance Bank (WAL) launched WA VenueX™, an institutional liquidity hub for the on‑chain economy — a sign banks are extending into digital‑asset infrastructure that could broaden future fee pools. Read the announcement.

Healthcare, biotech and regulatory moves

HCA Healthcare (HCA) reported 2Q26 results; operators and investors will parse case mix, admissions trends and margin sustainability as elective procedures and outpatient shifts evolve. Read the earnings note.

NewAmsterdam Pharma (NAMS) and Menarini received a positive CHMP opinion recommending marketing authorization for Ubeslo® (obicetrapib), a development that could reshape cholesterol‑treatment dynamics and uptake expectations. See the regulatory note.

Outlook Therapeutics (OTLK) announced LYTENAVA™ FDA approval as the first and only FDA‑approved ophthalmic bevacizumab for wet AMD. This is a landmark labeling and commercialization milestone that could materially change revenue and partnership prospects if uptake and reimbursement follow. Read the approval notice.

Software, AI, data and quantum

DigitalOcean (DOCN) reduced leverage with no effective dilution and minimal cash use, freeing capacity for growth — a notable capital‑allocation move for cloud infrastructure investors. See the statement.

Maison Solutions (MSS) signed to establish a majority‑controlled AI technology platform, a deal that signals consolidation and ambition to scale enterprise AI services. Read the deal note.

World Foundation / ORBS (ORBS) raised $52.5 million to expand its World ID infrastructure as AI reshapes identity on the internet. For investors tracking blockchain infrastructure and AI‑driven identity projects, the raise highlights continued funding interest in decentralized identity primitives. Read the funding announcement.

Quantum X Labs (QXL) reported meaningful error‑correction decoder results using NVIDIA CUDA‑Q QEC, progress that investors in quantum computing should watch as it affects roadmap credibility and potential partnerships. See the update.

IonQ (IONQ) will report 2Q26 financial results on August 5, adding another scheduled data point for market participants gauging adoption and commercialization progress in quantum hardware and services. See the earnings notice.

Defense, aerospace and robotics

Mobix Labs (MOBX) completed the acquisition of Vision Aerial, accelerating its national‑security drone platform and expanding systems integration capabilities — a move that can change contract runway for defense suppliers. Read the announcement.

Vertical Aerospace (EVTL) capped a landmark week at Farnborough, advancing commercial electric aviation timelines; such trade‑show momentum can spur orders and partnership activity. Read the update.

Consumer, media and services

Liberty Global (LBTYA) reported Q2 results; cable, broadband and advertising trends will shape subscriber and ARPU outlook for multi‑market operators. See the report.

Lamb Weston (LW) beat guidance for Q4 and fiscal 2026 with net sales and adjusted EBITDA above the high end, pointing to pricing power in branded food ingredients. Read the release.

Markets, filings and capital moves

ICE released a first look at mortgage performance showing new default activity posted an annual decline led by FHA loans — a timely data point for credit investors and mortgage‑exposed banks. See the report.

Chegg (CHGG) received a continued listing standard notice from the NYSE. For shareholders and prospective buyers, the action focuses attention on governance, balance sheet and any near‑term remediation the company must undertake. Read the notice.

Surf Air Mobility (SRFM) received a continued listing standard notice from the NYSE, joining a string of aviation and small‑cap listings under review; such notices can pressure liquidity and prompt near‑term balance‑sheet fixes. See the exchange notice.

Mdxhealth (MDXH) announced receipt of a Nasdaq notification regarding a minimum market value of listed securities deficiency. Investors should watch timelines for cure plans or potential delisting risks that could affect shareholder liquidity. Read the notification.

Fundrise Innovation Fund (VCX) will accelerate lockup expiration of restricted shares by one month, a change that could increase free float and near‑term selling pressure for the fund’s NYSE‑listed vehicle. See the announcement.

SK hynix (SKHY) will see leveraged ETFs tied to its stock start trading Tuesday via Tradr, a development that can add volatility and change intraday flow for the memory chip name as speculators gain easier leverage exposure. Read the announcement.

Brenmiller Energy (BNRG) announced a waiver from the European Investment Bank and advanced debt settlement talks to support its BrenX growth strategy, easing a financing overhang that had weighed on execution. Read the statement.

Deals, timing and what’s next

• Bullish / Siris (BLSH) said Siris will acquire non‑core Equiniti businesses as part of a strategic refocus; the carve‑out could reshape strategy and capital deployment. Read the note and transaction details.
• Gorman‑Rupp (GRC) named a CFO successor alongside 2Q results; investors will watch for any shifts in capital allocation or guidance cadence under new finance leadership. Read the earnings and the succession notice.

Notices, calls and smaller scheduling items

• CXApp Inc. (CXAI) set a date for its second‑quarter 2026 results and investor forum, a scheduled event investors can use to update estimates and sentiment.
• Lee Enterprises (LEE) plans a quarterly call and webcast on August 6, 2026; local media and publishing metrics will be the focus. See the notice.
• AMREP (AXR) reported fiscal 2026 results; the company’s land‑sales cadence and margin profile remain key items for valuation. Read the release.

Smaller corporate actions and governance

• Nektar Therapeutics (NKTR) reported inducement grants under Nasdaq rules; such hires can influence R&D direction and expense trajectories. Read the filing.
• SOLAI Limited (SLAI) announced an extraordinary general meeting, a governance event that could carry strategic implications depending on the agenda.
• Tianci International (CIIT) established a local operating entity in Zimbabwe, a step that may aid regional execution for revenue growth. See the announcement.
• Pelthos Therapeutics (PTHS) set its 2026 annual meeting of stockholders; proxy items and board votes will be watched. Read the notice.
• NovaBridge Biosciences (NBP) to hold its annual general meeting on September 8, 2026; small‑cap biotech governance updates can affect timelines for partnerships. See the notice.